At the molecular level, a significant loss of noradrenergic neurons in the LC was documented in AD, correlating with cognitive decline, as evidenced by mRNA expression for tyrosine hydroxylase (TH), α2A-AR, and NET, along with morphometric analysis [65, 78–81]. The gene discussed is TH; the disease is Alzheimer disease.